| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
84,844 |
74,390 |
$3.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,526 |
17,363 |
$1.24M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,170 |
16,247 |
$987K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
16,339 |
15,564 |
$938K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,012 |
12,238 |
$748K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
10,060 |
9,531 |
$572K |
| 99173 |
|
27,094 |
25,478 |
$404K |
| 3008F |
|
40,696 |
38,141 |
$341K |
| 92551 |
|
24,000 |
22,539 |
$277K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12,881 |
12,265 |
$272K |
| 83655 |
|
18,794 |
17,974 |
$252K |
| 99188 |
|
20,236 |
19,064 |
$247K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,086 |
1,986 |
$202K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,639 |
4,597 |
$168K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,391 |
8,578 |
$146K |
| D1208 |
Topical application of fluoride, excluding varnish |
10,248 |
9,877 |
$124K |
| 92587 |
|
2,295 |
2,204 |
$124K |
| 80061 |
Lipid panel |
9,181 |
8,660 |
$123K |
| 96127 |
|
19,906 |
18,420 |
$95K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,901 |
2,733 |
$78K |
| 90686 |
|
16,563 |
15,720 |
$77K |
| 36416 |
|
28,770 |
27,345 |
$70K |
| 85018 |
|
23,260 |
22,403 |
$62K |
| 88738 |
|
10,178 |
9,823 |
$56K |
| 99000 |
|
13,989 |
12,744 |
$50K |
| 90670 |
|
9,530 |
9,086 |
$44K |
| 82947 |
|
9,231 |
8,699 |
$35K |
| 90651 |
|
4,613 |
4,370 |
$33K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,535 |
1,498 |
$30K |
| 90647 |
|
5,361 |
5,134 |
$27K |
| 90707 |
|
4,841 |
4,613 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,222 |
2,171 |
$25K |
| 90633 |
|
5,112 |
4,881 |
$25K |
| 90716 |
|
4,929 |
4,699 |
$24K |
| 90723 |
|
4,792 |
4,581 |
$22K |
| 81002 |
|
7,567 |
7,208 |
$21K |
| 90680 |
|
3,999 |
3,819 |
$18K |
| 99460 |
|
143 |
135 |
$18K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
482 |
439 |
$17K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
290 |
184 |
$14K |
| 90620 |
|
1,064 |
991 |
$11K |
| 87807 |
|
874 |
758 |
$11K |
| 99050 |
|
1,158 |
1,059 |
$11K |
| 90734 |
|
2,083 |
2,023 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
224 |
216 |
$10K |
| 90619 |
|
942 |
834 |
$10K |
| 90672 |
|
504 |
468 |
$10K |
| 90715 |
|
1,070 |
1,008 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
110 |
95 |
$6K |
| 81025 |
|
663 |
581 |
$5K |
| 99223 |
Prolong inpt eval add15 m |
55 |
46 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
25 |
$4K |
| 96160 |
|
1,274 |
1,204 |
$4K |
| 90696 |
|
750 |
727 |
$3K |
| 90698 |
|
619 |
590 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
190 |
173 |
$2K |
| 99463 |
|
14 |
13 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
20 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
84 |
81 |
$1K |
| 90648 |
|
235 |
227 |
$1K |
| 99441 |
|
115 |
102 |
$1K |
| 90677 |
|
43 |
39 |
$1K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
222 |
205 |
$929.63 |
| 99383 |
|
14 |
14 |
$889.70 |
| 90700 |
|
217 |
214 |
$879.48 |
| 99382 |
|
16 |
13 |
$818.57 |
| 82948 |
|
406 |
316 |
$553.38 |
| 99442 |
|
28 |
24 |
$532.80 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36 |
14 |
$494.62 |
| 90744 |
|
105 |
103 |
$431.57 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
222 |
205 |
$406.00 |
| 90685 |
|
120 |
118 |
$405.09 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
146 |
120 |
$359.47 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,582 |
2,014 |
$332.76 |
| 86580 |
|
41 |
40 |
$263.31 |
| 90756 |
|
41 |
39 |
$146.70 |
| 90674 |
|
17 |
12 |
$135.00 |
| 36415 |
Collection of venous blood by venipuncture |
519 |
438 |
$32.10 |
| 94760 |
|
14 |
13 |
$12.98 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
115 |
112 |
$5.47 |
| 90461 |
|
81 |
59 |
$0.00 |